NY A9156B

The Assembly twin of S8925A - same 2% cap, same 1mg per serving limit.

We oppose this

Prohibits the sale of products that contain 7-hydroxymitragynine at a level that exceeds 2% of total alkaloids or one milligram per serving; establishes fines for the sale of such products.

What it does

Identical in substance to S8925A: caps 7-hydroxymitragynine at 2% of total alkaloids or one milligram per serving.
Establishes fines for sale above that threshold.
Has been substituted by S8925A, meaning the Senate bill is the one that now carries - but the Assembly position on the cap is what this bill records.

Where we agree with it

Saying this out loud matters. A representative who hears only opposition learns nothing about what we would actually vote for.

That a shopper should be able to know how strong what they are buying is.

What our model act does instead

We are not asking anyone to do nothing. Every objection below comes with the clause we would put in its place — the full text is here.

§13

No Alkaloid Caps; Mandatory Disclosure

Disclosure achieves what the cap is reaching for without taking the labeled product off the shelf. The buyer learns the same fact either way; only one of the two leaves them a legal place to buy it.

If you call, say this

Yours will be better than ours because it is yours. Change a word, say where you live, and stop — ninety seconds is a long call.

I am a constituent and I am asking you to oppose A9156B and its Senate twin S8925A. Label the 7-OH content, require lab testing, but do not cap it. A cap moves people to products nobody is testing.

Find who to call How a call goes